ASMB
Price
$18.35
Change
-$0.33 (-1.77%)
Updated
Jul 21, 03:31 PM (EDT)
Capitalization
142.67M
CVKD
Price
$10.97
Change
-$0.32 (-2.83%)
Updated
Jul 21, 03:50 PM (EDT)
Capitalization
22.2M
17 days until earnings call
Interact to see
Advertisement

ASMB vs CVKD

Header iconASMB vs CVKD Comparison
Open Charts ASMB vs CVKDBanner chart's image
Assembly Biosciences
Price$18.35
Change-$0.33 (-1.77%)
Volume$100
Capitalization142.67M
Cadrenal Therapeutics
Price$10.97
Change-$0.32 (-2.83%)
Volume$500
Capitalization22.2M
ASMB vs CVKD Comparison Chart in %
Loading...
ASMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASMB vs. CVKD commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASMB is a Hold and CVKD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (ASMB: $18.68 vs. CVKD: $11.29)
Brand notoriety: ASMB and CVKD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASMB: 191% vs. CVKD: 94%
Market capitalization -- ASMB: $142.67M vs. CVKD: $22.2M
ASMB [@Biotechnology] is valued at $142.67M. CVKD’s [@Biotechnology] market capitalization is $22.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASMB’s FA Score shows that 0 FA rating(s) are green whileCVKD’s FA Score has 0 green FA rating(s).

  • ASMB’s FA Score: 0 green, 5 red.
  • CVKD’s FA Score: 0 green, 5 red.
According to our system of comparison, ASMB is a better buy in the long-term than CVKD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASMB’s TA Score shows that 3 TA indicator(s) are bullish while CVKD’s TA Score has 5 bullish TA indicator(s).

  • ASMB’s TA Score: 3 bullish, 4 bearish.
  • CVKD’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CVKD is a better buy in the short-term than ASMB.

Price Growth

ASMB (@Biotechnology) experienced а -0.37% price change this week, while CVKD (@Biotechnology) price change was -12.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.79%. For the same industry, the average monthly price growth was +16.27%, and the average quarterly price growth was +35.62%.

Reported Earning Dates

CVKD is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASMB($143M) has a higher market cap than CVKD($22.2M). ASMB YTD gains are higher at: 18.378 vs. CVKD (-22.084). CVKD has higher annual earnings (EBITDA): -12.82M vs. ASMB (-44.5M). ASMB has more cash in the bank: 91M vs. CVKD (7.34M). CVKD has less debt than ASMB: CVKD (0) vs ASMB (3.02M). ASMB has higher revenues than CVKD: ASMB (32.2M) vs CVKD (0).
ASMBCVKDASMB / CVKD
Capitalization143M22.2M644%
EBITDA-44.5M-12.82M347%
Gain YTD18.378-22.084-83%
P/E RatioN/AN/A-
Revenue32.2M0-
Total Cash91M7.34M1,240%
Total Debt3.02M0-
FUNDAMENTALS RATINGS
ASMB: Fundamental Ratings
ASMB
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ASMBCVKD
RSI
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
87%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 12 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
80%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ASMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTVRF0.59N/A
N/A
Petro Victory Energy Corp.
DMCOF4.13N/A
N/A
d'Amico International Shipping SA
FSNUY11.88-0.11
-0.92%
Fresenius SE & Co. KGaA
MSSMY6.80-0.10
-1.52%
Misumi Group, Inc.
TTNN0.07-0.02
-17.75%
TITAN NRG

ASMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASMB has been loosely correlated with SPRC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ASMB jumps, then SPRC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASMB
1D Price
Change %
ASMB100%
-3.21%
SPRC - ASMB
45%
Loosely correlated
-6.22%
ABCZF - ASMB
44%
Loosely correlated
N/A
NKTX - ASMB
42%
Loosely correlated
-4.50%
RGNX - ASMB
37%
Loosely correlated
-6.10%
ZYME - ASMB
36%
Loosely correlated
-1.59%
More

CVKD and

Correlation & Price change

A.I.dvisor tells us that CVKD and GDTC have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVKD and GDTC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVKD
1D Price
Change %
CVKD100%
-4.89%
GDTC - CVKD
31%
Poorly correlated
-0.33%
MNPR - CVKD
29%
Poorly correlated
-1.63%
WHWK - CVKD
25%
Poorly correlated
-2.70%
RNXT - CVKD
25%
Poorly correlated
N/A
ASMB - CVKD
23%
Poorly correlated
-3.21%
More